Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach
| dc.contributor.author | Paulsen, C. Alvin | en_US |
| dc.contributor.author | Christensen, Richard B. | en_US |
| dc.contributor.author | Matsumoto, Alvin M. | en_US |
| dc.contributor.author | Bremner, William J. | en_US |
| dc.contributor.author | Bebb, Richard A. | en_US |
| dc.contributor.author | Anawalt, Bradley D. | en_US |
| dc.date.accessioned | 2008-10-17T20:41:20Z | |
| dc.date.available | 2008-10-17T20:41:20Z | |
| dc.date.issued | 1996-02 | en_US |
| dc.description.abstract | Studies using high dose testosterone (T) administration in normal men as a male contraceptive have resulted in azoospermia rates of only 50-70%. Previous studies of T and progestogen combinations have shown comparable rates of azoospermia, but have been uncontrolled or used T in doses less than that associated with maximal suppression of sperm production. We conducted a randomized, placebo-controlled, single blind trial comparing 6 months of T enanthate administration (100 mg, im, weekly) with the same dose of T enanthate in conjunction with the progestogen levonorgestrel (LNG; 500 micrograms, orally, daily) in 36 normal men, aged 20-42 yr (n = 18 in each group). The primary end points were induction of azoospermia or severe oligospermia (< 3 million sperm/mL). The combination of T plus LNG was much more effective in suppressing sperm production than T alone. Sixty-seven percent of the T plus LNG group (12 of 18) and 33% of the T alone group (6 of 18) achieved azoospermia by 6 months (P = 0.06). Severe oligospermia or azoospermia developed in 94% of the T plus LNG (17 of 18) group compared to 61% of the T alone group (11 of 18; P < 0.05). T plus LNG also suppressed sperm production more rapidly than T alone. Time to azoospermia was 9.9 +/- 1.0 vs. 15.3 +/- 1.9 weeks in the T plus LNG and T alone groups, respectively (mean +/- SEM; P < 0.05). Serum high density lipoprotein cholesterol decreased 21.7 +/- 3.6% in men given T plus LNG (P < 0.05), compared to only a 1.8 +/- 3.8% decrease in men in the T alone group. Average weight gain was 5.3 +/- 0.8 kg in the T plus LNG group and 2.3 +/- 0.9 kg in the T alone group (P < 0.05). Acne and increase in hemoglobin were similar in the two groups. We conclude that combination hormonal therapy with T plus a progestogen might offer a reversible male contraceptive approach with a more rapid onset of action and more reliable induction of both azoospermia and severe oligospermia than T alone. | en_US |
| dc.identifier.citation | J Clin Endocrinol Metab. 1996 Feb;81(2):757-62 | en_US |
| dc.identifier.uri | http://hdl.handle.net/1773/4348 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Endocrine Society | en_US |
| dc.subject | male contraception | en_US |
| dc.subject | 5-alpha reductase inhibitors | en_US |
| dc.subject | andrology | en_US |
| dc.subject | reifenstein's syndrome | en_US |
| dc.subject | gonadotropins | en_US |
| dc.subject | colchicine | en_US |
| dc.subject | spermatogenesis | en_US |
| dc.subject | testosterone | en_US |
| dc.subject | klinefelter's syndrome | en_US |
| dc.subject.mesh | Follicle Stimulating Hormone, blood | en_US |
| dc.subject.mesh | Weight Gain | en_US |
| dc.subject.mesh | Contraceptive Agents, Male, pharmacology | en_US |
| dc.subject.mesh | Levonorgestrel, administration & dosage, adverse effects, pharmacology | en_US |
| dc.subject.mesh | Luteinizing Hormone, blood | en_US |
| dc.subject.mesh | Humans | en_US |
| dc.subject.mesh | Research Support, U.S. Gov't, Non-P.H.S. | en_US |
| dc.subject.mesh | Male | en_US |
| dc.subject.mesh | Placebos | en_US |
| dc.subject.mesh | Sperm Count | en_US |
| dc.subject.mesh | Lipoproteins, HDL Cholesterol, blood | en_US |
| dc.subject.mesh | Adult | en_US |
| dc.subject.mesh | Research Support, Non-U.S. Gov't | en_US |
| dc.subject.mesh | Testosterone, administration & dosage, adverse effects, pharmacology | en_US |
| dc.subject.mesh | Spermatogenesis, drug effects | en_US |
| dc.subject.mesh | Research Support, U.S. Gov't, P.H.S. | en_US |
| dc.title | Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach | en_US |
| dc.type | Article | en_US |
